Maria-Clemencia Hernández

Public-private initiative to align EEG biomarkers of Alzheimer ’ s disease in human and mouse models for early stages of drug discovery : the achievements of IMI PharmaCog project

G. Frisoni, C. Babiloni, R. Lizio, 2017 .

Dendrite-targeting interneurons control synaptic NMDA-receptor activation via nonlinear α5-GABAA receptors

J. Bischofberger, J. M. Schulz, F. Knoflach, 2018, Nature Communications.

Enhanced Dendritic Inhibition and Impaired NMDAR Activation in a Mouse Model of Down Syndrome

J. Bischofberger, J. M. Schulz, F. Knoflach, 2019, The Journal of Neuroscience.

Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome

R. Vidal, Maria-Clemencia Hernández, C. Martínez-Cué, 2018, Molecular Neurobiology.

Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABA(A) alpha5 inverse agonist series.

F. Blasco, F. Knoflach, G. Trube, 2009, Bioorganic & medicinal chemistry letters.

Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunction.

F. Knoflach, G. Trube, Maria-Clemencia Hernández, 2009, Bioorganic & medicinal chemistry letters.

Electrophysiological Phenotype in Angelman Syndrome Differs Between Genotypes

Meghan T. Miller, J. Hipp, A. Rotenberg, 2019, Biological Psychiatry.

Pharmacological interventions to improve cognition and adaptive functioning in Down syndrome: Strides to date

Sarah J. Hart, Cesar Ochoa-Lubinoff, Maria-Clemencia Hernández, 2017, American journal of medical genetics. Part A.

19th biennial IPEG Meeting

Asbjørn Mohr Drewes, Vitoantonio Bevilacqua, Roshan Cools, 2016 .